<DOC>
	<DOCNO>NCT00002453</DOCNO>
	<brief_summary>This study allow patient need new anti-HIV treatment take tenofovir disoproxil fumarate ( tenofovir DF ) , experimental drug . This study also look side effect drug cause .</brief_summary>
	<brief_title>A Compassionate Use Study Tenofovir Disoproxil Fumarate Treatment HIV Infection</brief_title>
	<detailed_description>HIV-1-infected patient currently receive stable antiretroviral therapy add tenofovir DF regimen . Study participation last approximately 48 week . Interested patient contact physician .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<mesh_term>Anti-Retroviral Agents</mesh_term>
	<criteria>Inclusion Criteria You may eligible study : Are HIVpositive . Have viral load great equal 10,000 copies/ml . Have CD4 count less equal 50 cells/mm3 , CD4 count great 50 200 cells/mm3 opportunistic ( AIDSrelated ) infection within 90 day study entry . ( Patients CD4 count 200 cells/mm3 may consider depend drug supply . ) Are least 18 year old . Agree use barrier method birth control ( condom ) study 30 day afterward . Have life expectancy least one year . Exclusion Criteria You eligible study : Have history serious kidney bone disease . Have severe nausea , vomit , trouble take medication mouth . Are pregnant breastfeeding . Abuse alcohol substance doctor think would interfere take medicine . Are take medicine interfere kidney function .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2000</verification_date>
	<keyword>HIV-1</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Disease Progression</keyword>
	<keyword>Anti-HIV Agents</keyword>
</DOC>